Research Article
The Analysis of bcl-2 in Association with p53 and Ki-67 in Triple Negative Breast Cancer and Other Molecular Subtypes in Ghana
Table 3
Distribution of biomarker expressions in breast cancer patients.
| | Biomarker | Percentage expressed (%) |
| | bcl-2 | | Positive | 37.9 | | Negative | 62.1 |
| | ER | | Positive | 29.0 | | Negative | 71.0 |
| | PR | | Positive | 10.9 | | Negative | 89.1 |
| | HER2 overexpression | | Positive | 20.7 | | Negative | 79.3 |
| | p53 | | Positive | 36.7 | | Negative | 63.3 |
| | Ki-67 | | Low (mild) | 62.1 | | Moderate | 16.5 | | High (severe) | 21.4 |
|
|
